| Q39223377 | 3-methoxytyramine and different neuroleptics: Dissociation from HVA and DOPAC |
| Q66943522 | A Golgi study of the ventral tegmental area of Tsai and interfascicular nucleus in the rat |
| Q28643908 | A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions |
| Q72607557 | A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone |
| Q66987131 | A presynaptic action of dopamine on globus pallidus afferents to substantia nigra in the rat |
| Q48198829 | A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system |
| Q49135033 | ARPP-21, a cAMP-regulated phosphoprotein enriched in dopamine-innervated brain regions: tissue distribution and regulation of phosphorylation in rat brain |
| Q40244859 | Absence of dopamine sensitive adenylate cyclase in the A10 region, the origin of mesolimbic dopamine neurones |
| Q48218030 | Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus and corpus striatum of rat |
| Q40139259 | Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra |
| Q49153005 | Caffeine potentiation of apomorphine discrimination |
| Q72939498 | Characterization of the dopamine stimulated adenylate cyclase in the pedal ganglia of Mytilus edulis: interactions with etorphine, beta-endorphin, DALA, and methionine enkephalin |
| Q66939899 | Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area |
| Q40089318 | Comparative aspects of opioid-dopamine interaction |
| Q40246300 | Cyclic nucleotide phosphodiesterase localization in nerve terminals of the rat substantia nigra |
| Q41222798 | Dendritic monoamines in the squirrel monkey brain |
| Q48806288 | Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections |
| Q37314975 | Developments in the pharmacology and therapeutics of parkinsonism |
| Q71278026 | Differential effect of haloperidol on DOPAC levels in the substantia nigra and ventral tegmental area |
| Q40208969 | Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus |
| Q48174113 | Direct evidence for presynaptic and postsynaptic dopamine receptors in brain |
| Q39251718 | Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra |
| Q49120173 | Distribution and cellular localization of DARPP-32 mRNA in rat brain |
| Q40068250 | Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studies |
| Q48243762 | Dopamine receptor sensitivity in brain and retina of rats during aging |
| Q40243147 | Dopamine receptors in the central nervous system. |
| Q39133872 | Dopamine-Sensitive Adenylate Cyclase: Location in Substantia Nigra |
| Q51406394 | Droperidol suppresses spontaneous electrical activity in neurons cultured from ventral midbrain. Implications for neuroleptanesthesia. |
| Q70169170 | Effects of dopamine on exocrine secretion and cyclic nucleotide concentration in the dog pancreas |
| Q39174784 | Evidence concerning the anatomical location of the dopamine stimulated adenylate cyclase in the substantia nigra |
| Q48253796 | Evidence for selective and long-lasting stimulation of “regulatory” dopamine-receptors by bromocriptine (CB 154) |
| Q48146434 | Function of nigral dopamine receptors? |
| Q66965226 | Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area |
| Q39930658 | Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro |
| Q35028210 | L-3,4-dihydroxyphenylalanine-induced hypersensitivity simulating features of denervation |
| Q39149367 | Localization of Nigral Dopamine-Sensitive Adenylate Cyclase on Neurons Originating from the Corpus Striatum |
| Q37818979 | Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines |
| Q39771859 | Multiple classes of dopamine receptors in mammalian central nervous system: The involvement of dopamine-sensitive adenylyl cyclase |
| Q40122664 | Multiple receptors for brain dopamine in behavior regulation: Concept of dopamine-e and dopamine-i receptors |
| Q37876912 | Multiple receptors for dopamine |
| Q39137711 | Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat |
| Q40085068 | Neurotransmitter Receptors: Neuroanatomical Localization Through Autoradiography |
| Q39773343 | Pharmacology and Neurochemistry of Apomorphine |
| Q48299825 | Possible relationship between glial cells, dopamine and the effects of antipsychotic drugs |
| Q44725028 | Postsynaptic receptors are not essential for dopaminergic feedback regulation |
| Q35013822 | Quantitative correlation of dopamine-dependent adenylate cyclase with responses to levodopa in various mice |
| Q48306174 | Release of dopamine in vivo from cat substantia nigra |
| Q49132039 | Stereoselectivity of presynaptic autoreceptors modulating dopamine release |
| Q40252604 | Storage and release of amines, amino acids and peptides from dendrites |
| Q40160365 | Subcellular distribution of dopamine in substantia nigra of the rat brain: effects of gamma-butyrolactone and destruction of noradrenergic afferents suggest formation of particles from dendrites |
| Q40057602 | Subcellular localization of cyclic nucleotide phosphodiesterase in the caudate nucleus |
| Q35428321 | Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro |
| Q38003131 | The Formation, Degradation, and Function of Cyclic Nucleotides in the Nervous System |
| Q51867204 | The effects of chloral hydrate anesthesia on the metabolic response in the substantia nigra to apomorphine |
| Q72466803 | The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra |
| Q40082826 | The physiology and pharmacology of mammalian basal ganglia |
| Q40083058 | The psychopharmacology of astroglial cells |
| Q31804333 | The reverse transport of DA, what physiological significance? |
| Q38075185 | The striatum and substantia nigra: A commentary on their relationships |
| Q39199744 | The use of kainic acid in the localization of enzymes in the substantia nigra |
| Q48122209 | Ultrastructural demonstration of adenylate cyclase activity in the rat neostriatum |
| Q41173089 | Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae |
| Q48153303 | d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway |